Learn More About the Mirum Clinical Trials

The VISTAS Study is seeking patients ages 12 and older with PSC to learn if the investigational medication, volixibat, might be an effective and safe treatment option for itch due to PSC.

The VANTAGE Study is seeking adults with PBC to learn if the investigational medication, volixibat, might be an effective and safe treatment option for itch due to PBC.

Travel related expenses may be reimbursed/provided as permitted by study site policies.

You may be eligible for either the VISTAS or VANTAGE clinical trial if you are:

Diagnosed with one of the following types of progressive inflammatory liver disease:

Primary Sclerosing Cholangitis
Primary Biliary Cholangitis

VISTAS: 12 years of age or older

VANTAGE: 18 years of age or older

Currently Suffering from Itch

Am I a Candidate?

ENROLLING PSC AND PBC PATIENTS WITH ITCH.

NOW WITH THE OPTION TO PARTICIPATE
FROM THE COMFORT OF YOUR HOME.

Learn More About the Mirum Clinical Trials

You may be eligible for either the VISTAS or VANTAGE clinical trial if you are:

Diagnosed with one of the following types of progressive inflammatory liver disease:

VISTAS: 12 years of age or older

VANTAGE: 18 years of age or older

Currently Suffering from Itch

ENROLLING PSC AND PBC PATIENTS WITH ITCH.

NOW WITH THE OPTION TO PARTICIPATE FROM THE COMFORT OF YOUR HOME.

Learn More About the Mirum Clinical Trials

You may be eligible for either the VISTAS or VANTAGE clinical trial if you are:

Diagnosed with one of the following types of progressive inflammatory liver disease:

VISTAS: 12 years of age or older

VANTAGE: 18 years of age or older

Currently Suffering from Itch

NOW WITH THE OPTION TO PARTICIPATE
FROM THE COMFORT OF YOUR HOME.